{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:42:52Z","timestamp":1775047372810,"version":"3.50.1"},"reference-count":32,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,2]]},"abstract":"<jats:p>Despite the potential benefit of primaquine in reducing <jats:italic>Plasmodium falciparum<\/jats:italic> transmission and radical cure of <jats:italic>Plasmodium vivax<\/jats:italic> and <jats:italic>Plasmodium ovale<\/jats:italic> infections, concerns over risk of hemolytic toxicity in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) have hampered its deployment. A cross-sectional survey was conducted in 2014 to assess the G6PDd prevalence among 631 children between 6 and 59 months of age in southwestern Uganda, an area where primaquine may be a promising control measure. G6PDd prevalence was determined using three detection methods: a quantitative G6PD enzyme activity assay (Trinity Biotech<jats:sup>\u00ae<\/jats:sup> G-6-PDH kit), a qualitative point-of-care test (CareStart<jats:sup>\u2122<\/jats:sup> G6PD rapid diagnostic test [RDT]), and molecular detection of the <jats:italic>G6PD A<\/jats:italic>\u2212 G202A allele. Qualitative tests were compared with the gold standard quantitative assay. G6PDd prevalence was higher by RDT (8.6%) than by quantitative assay (6.8%), using a &lt; 60% activity threshold. The RDT performed optimally at a &lt; 60% threshold and demonstrated high sensitivity (\u2265 90%) and negative predictive values (100%) across three activity thresholds (below 60%, 30%, and 40%). G202A allele frequency was 6.4%, 7.9%, and 6.8% among females, males, and overall, respectively. Notably, over half of the G202A homo-\/hemizygous children expressed \u2265 60% enzyme activity. Overall, the CareStart<jats:sup>\u2122<\/jats:sup> G6PD RDT appears to be a viable screening test to accurately identify individuals with enzyme activities below 60%. The low prevalence of G6PDd across all three diagnostic modalities and absence of severe deficiency in our study suggests that there is little barrier to the use of single-dose primaquine in this region.<\/jats:p>","DOI":"10.4269\/ajtmh.16-0552","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T03:48:47Z","timestamp":1474948127000},"page":"1094-1099","source":"Crossref","is-referenced-by-count":18,"title":["Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda"],"prefix":"10.4269","volume":"95","author":[{"given":"Michelle E.","family":"Roh","sequence":"first","affiliation":[{"name":"Yale School of Public Health, New Haven, Connecticut."},{"name":"University of California, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caesar","family":"Oyet","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology, Mbarara, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Orikiriza","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology, Mbarara, Uganda."},{"name":"M\u00e9decins sans Fronti\u00e8res Epicentre, Mbarara Research Centre, Mbarara, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Wade","sequence":"additional","affiliation":[{"name":"Yale School of Public Health, New Haven, Connecticut."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Mwanga-Amumpaire","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology, Mbarara, Uganda."},{"name":"M\u00e9decins sans Fronti\u00e8res Epicentre, Mbarara Research Centre, Mbarara, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yap","family":"Boum","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology, Mbarara, Uganda."},{"name":"M\u00e9decins sans Fronti\u00e8res Epicentre, Mbarara Research Centre, Mbarara, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertrude N.","family":"Kiwanuka","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology, Mbarara, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Parikh","sequence":"additional","affiliation":[{"name":"Yale School of Public Health, New Haven, Connecticut."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"ref1","series-title":"Policy Brief on Single-Dose Primaquine as a Gametocytocide in Plasmodium falciparum Malaria","author":"World Health Organization","year":"2015"},{"key":"ref2","series-title":"Malar J","first-page":"1","article-title":"Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report","volume":"12","author":"von Seidlein","year":"2013"},{"key":"ref3","series-title":"Malar J","first-page":"1","article-title":"Tools for mass screening of G6PD deficiency: validation of the WST8\/1-methoxy-PMS enzymatic assay in Uganda","volume":"12","author":"De Niz","year":"2013"},{"key":"ref4","series-title":"Malar J","first-page":"1186","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"Ashley","year":"2014"},{"key":"ref5","series-title":"Hematol Oncol Clin North Am","first-page":"373","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"30","author":"Luzzatto","year":"2016"},{"key":"ref6","series-title":"Malar J","first-page":"391","article-title":"G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests","volume":"12","author":"Domingo","year":"2013"},{"key":"ref7","series-title":"Guidelines for the Treatment of Malaria","author":"World Health Organization","year":"2015"},{"key":"ref8","series-title":"Point-of-Care G6PD Testing to Support Safe Use of Primaquine for the Treatment of Vivax Malaria","author":"Malaria Policy Advisory Committee Meeting","year":"2015"},{"key":"ref9","series-title":"Blood","first-page":"4123","article-title":"Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone","volume":"120","author":"Pamba","year":"2012"},{"key":"ref10","series-title":"Emerg Infect Dis","first-page":"1494","article-title":"Asymptomatic Plasmodium infections in children in low malaria transmission setting, southwestern Uganda","volume":"22","author":"Roh","year":"2016"},{"key":"ref11","series-title":"Training for Mid-Level Managers (MLM): The Epi Coverage Survey","author":"World Health Organization","year":"2008"},{"key":"ref12","series-title":"PLoS One","first-page":"e7246","article-title":"Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility","volume":"4","author":"Johnson","year":"2009"},{"key":"ref13","series-title":"PLoS One","first-page":"e28357","article-title":"Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening","volume":"6","author":"Kim","year":"2011"},{"key":"ref14","series-title":"Bull World Health Organ","first-page":"601","article-title":"Glucose-6-phosphate dehydrogenase deficiency. WHO working group","volume":"67","author":"World Health Organization","year":"1989"},{"key":"ref15","series-title":"Malar J","first-page":"132","article-title":"Heterogeneous decrease in malaria prevalence in children over a six-year period in south-western Uganda","volume":"10","author":"De Beaudrap","year":"2011"},{"key":"ref16","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2013"},{"key":"ref17","series-title":"Transl Res","first-page":"677","article-title":"Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells","volume":"165","author":"Baird","year":"2015"},{"key":"ref18","series-title":"Nat Commun","first-page":"1237","article-title":"Factors determining the occurrence of submicroscopic malaria infections and their relevance for control","volume":"3","author":"Okell","year":"2012"},{"key":"ref19","series-title":"BMC Res Notes","first-page":"372","article-title":"Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga district in Uganda","volume":"7","author":"Bwayo","year":"2014"},{"key":"ref20","series-title":"Population Estimates for G6PD Deficiency Table for Uganda","author":"Malaria Atlas Project"},{"key":"ref21","series-title":"Malar J","first-page":"270","article-title":"Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali","volume":"13","author":"Maiga","year":"2014"},{"key":"ref22","series-title":"BMC Med Genet","first-page":"93","article-title":"Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya","volume":"15","author":"Shah","year":"2014"},{"key":"ref23","series-title":"Eur J Hum Genet","first-page":"1080","article-title":"Allelic heterogeneity of G6PD deficiency in west Africa and severe malaria susceptibility","volume":"17","author":"Clark","year":"2009"},{"key":"ref24","series-title":"PLoS One","first-page":"e0125796","article-title":"Evaluation of the diagnostic accuracy of CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa","volume":"10","author":"Adu-Gyasi","year":"2015"},{"key":"ref25","series-title":"PLoS Negl Trop Dis","first-page":"e0004457","article-title":"Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural eastern Indonesia","volume":"10","author":"Satyagraha","year":"2016"},{"key":"ref26","series-title":"Am J Trop Med Hyg","first-page":"77","article-title":"Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti","volume":"91","author":"von Fricken","year":"2014"},{"key":"ref27","series-title":"PLoS One","first-page":"e116143","article-title":"Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia","volume":"9","author":"Roca-Feltrer","year":"2014"},{"key":"ref28","series-title":"Uganda Malaria Indicator Survey 2009","author":"Uganda Bureau of Statistics (UBOS) and ICF International","year":"2010"},{"key":"ref29","series-title":"Uganda Malaria Indicator Survey 2014\u20132015","author":"Uganda Bureau of Statistics (UBOS) and ICF International","year":"2015"},{"key":"ref30","series-title":"PLoS One","first-page":"e0151898","article-title":"Single low dose primaquine (0.25 mg\/kg) does not cause clinically significant haemolysis in G6PD deficient subjects","volume":"11","author":"Bancone","year":"2016"},{"key":"ref31","series-title":"Am J Trop Med Hyg","first-page":"79","article-title":"Vivax malaria: neglected and not benign","volume":"77","author":"Price","year":"2007"},{"key":"ref32","series-title":"Malar J","first-page":"360","article-title":"Rationale for short course primaquine in Africa to interrupt malaria transmission","volume":"11","author":"Eziefula","year":"2012"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/95\/5\/article-p1094.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/95\/5\/article-p1094.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/95\/5\/article-p1094.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T21:53:30Z","timestamp":1723067610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/95\/5\/article-p1094.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":32,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.16-0552","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}